People · Operator
Named in public records as an officer, director or promoter · active 2017–2023 · Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Episteme Prognostics, Inc. | — | Biotechnology | Series A | $4.7M | $2.1M | 2023 |
| Cage Pharmaceuticals, Inc. | — | Biotech / Pharma | Pre-Seed | $967K | $696K | 2017 |
Jason Rifkin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason Rifkin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Isaac Ro | 1 | 4 |
| Gregory Ho | 1 | 4 |
| Gregory P Ho | 1 | 2 |
| Robert Warren | 1 | 2 |
| Peter Olagunju | 1 | 2 |
| Nick Papadopoulos | 1 | 1 |
| Jason P. Rifkin | 1 | 1 |
| Surajit Dhara | 1 | 1 |
| Robert P. Warren | 1 | 1 |
| Brian Malik | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.